The Moon Phase

[umiak]

GNVC--quick look:
21.5m market cap
13.5m revenue
diluted eps -.84
total cash 21m
Q yoy growth -46%
pps 9/11 2.50-3.00
os 13m float 11m

http://finance.yahoo.com/q/ks?s=GNVC+Key+Statistics

http://www.genvec.com/

Business Summary
GenVec, Inc. operates as a biopharmaceutical company that uses differentiated and proprietary technologies to create therapeutics and vaccines. The company develops and commercializes its product candidates through collaborations with various companies and organizations, including Novartis, Merial, and the U.S. Government to support a portfolio of product programs that address the prevention and treatment of various human and animal health concerns. Its development programs address various therapeutic areas, such as hearing loss and balance disorders; and vaccines against infectious diseases comprising respiratory syncytial virus, herpes simplex virus, dengue fever, and malaria. The company is also involved in developing vaccines against foot-and-mouth disease. GenVec, Inc. was founded in 1992 and is based in Gaithersburg, Maryland.